The comparison between the signaling proteins triggered by the two vp17s allowed to also identify the contribution of other proliferation-regulating molecules specific for each variant: CHEK1, CHEK2, JAK1, and CDK4, for NHL-a101; MAPK8, RAF1, and CDK2 for NHL-a102. Here, CHEK2 is linked to non-Hodgkin lymphoma.